Shanghai Lechun Biotechnology

Launch date

2011

Employees

Market cap

Enterprise valuation

Songjiang District China (HQ)

Date	Investors	Amount	Round
Apr 2021*	N/A	CNY200m	Series B
Dec 2021	Hillhouse Capital New Alliance Capital Huimei Technology	N/A	Series B
Jan 2023*	General Atlantic Goldman Sachs Novo Holdings China Science and Technology Innovation Kangjun Capital HM Capital Honghui Capital Huaying Health Fund	CNY200m	Series C
Total Funding		$55.0m

Recent News about Shanghai Lechun Biotechnology